{"transactions":[{"id":674505,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2026-08-26T21:30:00.000Z","date":"2026-08-24","kind":"exercise","planned":false,"acquired":false,"shares":337204,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":337204},"source":{"system":"sec-edgar","filing":"0001493152-26-040276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226040276/ownership.xml","form_type":"4"}},{"id":674504,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2026-08-26T21:30:00.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":337204,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."}],"balance_after":337204,"derivative":{"underlying":"Common Stock","underlying_shares":337204},"source":{"system":"sec-edgar","filing":"0001493152-26-040276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226040276/ownership.xml","form_type":"4"}},{"id":674503,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"Stock Options","published_at":"2026-08-26T21:30:00.000Z","date":"2026-08-24","kind":"exercise","planned":false,"acquired":false,"shares":337204,"price":6.94,"value":2340195.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Following approval by the Company's Board of Directors and stockholders of the cancellation of stock options issued under the 2017 Innovative Health Solutions, Inc. Stock Compensation Plan and the grant of an equivalent number of RSUs under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan, the reporting person's stock options were canceled in exchange for an equivalent number of RSUs, which vested immediately upon grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":337204},"source":{"system":"sec-edgar","filing":"0001493152-26-040276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226040276/ownership.xml","form_type":"4"}},{"id":674502,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"Common Stock","published_at":"2026-08-26T21:30:00.000Z","date":"2026-08-24","kind":"grant","planned":false,"acquired":true,"shares":199106,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reference is made to the 337,204 restricted stock units (\"RSUs\") granted and vested to the Reporting Person under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan as discussed below, of which 138,098 shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reference is made to the 337,204 restricted stock units (\"RSUs\") granted and vested to the Reporting Person under the NeurAxis, Inc. 2022 Omnibus Securities and Incentive Plan as discussed below, of which 138,098 shares were withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs."}],"balance_after":199106,"source":{"system":"sec-edgar","filing":"0001493152-26-040276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226040276/ownership.xml","form_type":"4"}},{"id":685005,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2026-08-17T22:36:02.000Z","date":"2026-08-13","kind":"grant","planned":false,"acquired":true,"shares":133341,"price":6.28,"value":837381.48,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."}],"balance_after":133341,"derivative":{"underlying":"Common Stock","underlying_shares":133341},"source":{"system":"sec-edgar","filing":"0001493152-26-038829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226038829/ownership.xml","form_type":"4"}},{"id":873312,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2026-03-02T21:10:28.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":47569,"price":4.63,"value":220244.47,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period."}],"balance_after":47569,"derivative":{"underlying":"Common Stock","underlying_shares":47569},"source":{"system":"sec-edgar","filing":"0001493152-26-008545","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000149315226008545/ownership.xml","form_type":"4"}},{"id":1043648,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2025-09-10T10:32:50.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":2.42,"value":84700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001641172-25-027022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000164117225027022/ownership.xml","form_type":"4"}},{"id":1043647,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2025-09-10T10:32:50.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":2.18,"value":65400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001641172-25-027022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000164117225027022/ownership.xml","form_type":"4"}},{"id":1043646,"issuer":{"id":6994,"kind":"organization","name":"Neuraxis, INC","symbol":"NRXS"},"owners":[{"id":19337,"kind":"person","name":"Miranda Adrian","position":1,"cik":"0001992525","reported_name":"Miranda Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, SVP Science & Tech"}}],"security":"RSU","published_at":"2025-09-10T10:32:50.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":2.18,"value":21800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of common stock are restricted stock units (RSUs) granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001641172-25-027022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933567/000164117225027022/ownership.xml","form_type":"4"}}]}